Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Zablocki

Edward Zablocki, North Andover, MA US

Patent application numberDescriptionPublished
20090189785Method and apparatus for reporting a missle threat to a commercial aircraft - An automatic system is provided for alerting ground personnel as to the existence of a threat to commercial aircraft in which the threat is determined by a classified system, but in which the local area network employed by the military missile warning is isolated from an unclassified local network coupled to the aircraft's transponder which transmits the threat existence and status to ground personnel. The barrier to transmitting classified information involves both filtering between the classified LAN and unclassified LAN, the use of only discrete signaling lines in the classified LAN isolated by opto-electronics to provide physical separation between the two local area networks, and communications formatting which precludes the transmission of classified information across the barrier between the classified local area network and the unclassified local area network.07-30-2009

Jarret Zablocki US

Patent application numberDescriptionPublished
20110252864Emissions Test System And Method - An emission test system may include at least one controller configured to determine, directly or indirectly, a quantity of diluted exhaust sample in a container at the completion of an emissions test, and to cause additional diluent gas to be added to the container based on the determined quantity.10-20-2011

Jeff A. Zablocki, Mountain View, CA US

Patent application numberDescriptionPublished
20100081810C-Pyrazole A2A Receptor Agonists - 2-adenosine C-pyrazole compounds having formula (a) and methods for using the compounds as A2A receptor agonists to stimulate mammalian coronary vasodilatation for therapeutic purposes and for purposes of imaging the heart.04-01-2010
20100160620N-PYRAZOLE A2A RECEPTOR AGONISTS - 2-adenosine N-pyrazole compounds having the following formula:06-24-2010
20110144320N-PYRAZOLE A2A RECEPTOR AGONISTS - 2-adenosine N-pyrazole compounds having the following formula:06-16-2011

Patent applications by Jeff A. Zablocki, Mountain View, CA US

Jeffery Zablocki, Mountain View, CA US

Patent application numberDescriptionPublished
20090054457SUBSTITUTED HETEROCYCLIC COMPOUNDS - Disclosed are novel substituted heterocyclic derivatives having the structure of Formula I:02-26-2009

Patent applications by Jeffery Zablocki, Mountain View, CA US

Mary-Margaret Zablocki, Fairfield, CT US

Patent application numberDescriptionPublished
20110190336AZABENZIMIDAZOLONES - Compounds are provided having the general structure of formula I:08-04-2011

Mary-Margaret E. Zablocki, Fairfield, CT US

Patent application numberDescriptionPublished
20090149450SUBSTITUTED IMIDAZOHETEROCYCLES - The present invention provides substituted imidazoheterocyclic compounds having the structure of formula I06-11-2009
20110034443USES OF SUBSTITUTED IMIDAZOHETEROCYCLES - The present invention provides methods of prevention and treatment of cannabinoid receptor-associated diseases and conditions, wherein the method includes administering a substituted imidazoheterocyclic compounds having the structure of formula I or a pharmaceutically acceptable salt, acid salt, hydrate, solvate or stereoisomer of a compound having the structure of formula I.02-10-2011

Mathew J. Zablocki, Newark, DE US

Patent application numberDescriptionPublished
20110230035Transfer Method for Thin Film Nanomembrane Structures - A transfer process for silicon nanomembranes (SiNM) may involve treating a recipient substrate with a polymer structural support. After treating the recipient substrate, a substrate containing the intended transferable devices may be brought in direct contact with the aforementioned polymer layer. The two substrates may then go through a Deep Reactive Ion Etch (DRIE) to remove at least a portion of the substrate containing the devices. Oxide may be selectively removed with a buffered oxide wet etch, leaving the transferred SiNM on the recipient substrate with the Underlying polymer layer.09-22-2011

Mathew Joseph Zablocki, Newark, DE US

Patent application numberDescriptionPublished
20110305456OPTICAL ROUTER - An optical routing element may include a planar dielectric photonic crystal which includes a lattice of holes having a first linear defect adjacent a second linear defect, with the two defects being separated by a central row of lattice holes. The first linear defect in the lattice of holes may form a first single mode line defect waveguide, and the second linear defect in the lattice of holes may form a second single mode line defect waveguide. Optical energy may be selectively coupled between the first and second waveguides across the central row of lattice holes. A free-carrier injector may be included to inject free-carriers into the dielectric photonic crystal, activation of which may alter selectivity of the optical coupling between the first and second waveguides. A plurality of optical routing elements with associated free-carrier injectors may be interconnected to form a bi-directional optical routing array.12-15-2011

Rong Zablocki, San Diego, CA US

Patent application numberDescriptionPublished
20110177531Cell-Based Complement Activation Product Algorithm for Diagnosing Systemic Lupus Erythematosus - The present invention provides methods of diagnosing and monitoring systemic lupus erythematosus by measuring cell-based complement activation products (CB-CAPS) in a subject's blood. In particular, the invention describes a diagnostic method employing the measurement of multiple complement activation products on the surfaces of red blood cells, white blood cells, and platelets (e.g., EC4d, BC4d, PC4d, and ECR1). A diagnostic algorithm utilizing the determined levels of CB-CAPS is also disclosed.07-21-2011